IP Verse

Risk-Stratification Of B-Precursor Acute Lymphoblastic Leukemia Patients

Patent No. EP3149480 (titled "Risk-Stratification Of B-Precursor Acute Lymphoblastic Leukemia Patients") was filed by Amgen on May 20, 2015. The application was issued on Dec 26, 2018.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
SANOFISep 26, 2019CABINET NONY
SANOFISep 26, 2019IPSILON

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3149480

AMGEN
Application Number
EP15727072A
Filing Date
May 20, 2015
Status
Revoked
Sep 17, 2021
Publication Date
Dec 26, 2018
External Links
Slate, Register , Google Patents